Profil
Jason Slingsby was the founder of ProtAffin Biotechnologie AG, founded in 2005, where the title held was Chief Executive Officer.
Dr. Slingsby is currently Chief Executive Officer at Tozaro Ltd., starting in 2025.
Former jobs include Chief Business Officer at Oxford Biomedica Plc from 2018 to 2023, Principal at InterCel, Inc., Principal at Sosei Co. Ltd., and Member-Supervisory Board at Zytoprotec GmbH.
Education includes a doctorate from Imperial College London and an MBA from London Business School.
Aktiva positioner av Jason Slingsby
| Företag | Position | Start |
|---|---|---|
MIP Discovery Ltd. (United Kingdom)
MIP Discovery Ltd. (United Kingdom) BiotechnologyHealth Technology Develops and manufactures viral vectors in cell & gene therapy | Verkställande Direktör | 2025-06-09 |
Tidigare kända positioner av Jason Slingsby
| Företag | Position | Slut |
|---|---|---|
| OXFORD BIOMEDICA PLC | Företagsledare/Principal | 2023-05-01 |
Zytoprotec GmbH
Zytoprotec GmbH Medical/Nursing ServicesHealth Services Provides dialysis renal replacement therapy services | Direktör/Styrelseledamot | - |
Sosei Co. Ltd.
Sosei Co. Ltd. Miscellaneous Commercial ServicesCommercial Services Researches and develops bio pharmaceutical drugs and provides services in clinical test preparation | Företagsledare/Principal | - |
InterCel, Inc.
InterCel, Inc. Wireless TelecommunicationsCommunications Operates cellular telephone system | Företagsledare/Principal | - |
ProtAffin Biotechnologie AG
ProtAffin Biotechnologie AG Pharmaceuticals: MajorHealth Technology Develops anti-inflammatory products | Verkställande Direktör | - |
Jason Slingsbys utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 8 |
|---|---|
Oxford Biomedica Plc
Oxford Biomedica Plc BiotechnologyHealth Technology Operates as a contract development and manufacturing organization which provides viral vectors to pharmaceutical and biotechnology clients in cell and gene therapy fields | Health Technology |
Imperial College London
Imperial College London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
InterCel, Inc.
InterCel, Inc. Wireless TelecommunicationsCommunications Operates cellular telephone system | Communications |
Sosei Co. Ltd.
Sosei Co. Ltd. Miscellaneous Commercial ServicesCommercial Services Researches and develops bio pharmaceutical drugs and provides services in clinical test preparation | Commercial Services |
London Business School
London Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ProtAffin Biotechnologie AG
ProtAffin Biotechnologie AG Pharmaceuticals: MajorHealth Technology Develops anti-inflammatory products | Health Technology |
Zytoprotec GmbH
Zytoprotec GmbH Medical/Nursing ServicesHealth Services Provides dialysis renal replacement therapy services | Health Services |
MIP Discovery Ltd. (United Kingdom)
MIP Discovery Ltd. (United Kingdom) BiotechnologyHealth Technology Develops and manufactures viral vectors in cell & gene therapy | Health Technology |
















